Update in sepsis 2012. (Q38114486)

29 August 2017

Update in sepsis 2012. (English)

1 reference

29 August 2017

0 references

James A Russell

1

1 reference

PubMed ID

23767902

29 August 2017

Keith R Walley

series ordinal

2

1 reference

PubMed ID

23767902

29 August 2017

language of work or name

English

0 references

publication date

1 June 2013

1 reference

American Journal of Respiratory and Critical Care Medicine

29 August 2017

1 reference

29 August 2017

187

1 reference

29 August 2017

12

1 reference

29 August 2017

1303-1307

1 reference

Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.

29 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Fever control using external cooling in septic shock: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Comparison of two fluid-management strategies in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Natriuretic peptide-driven fluid management during ventilator weaning: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

One-year outcomes in survivors of the acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Self-reported depressive symptoms and memory complaints in survivors five years after ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Functional disability 5 years after acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Spurious inferences about long-term outcomes: the case of severe sepsis and geriatric conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

The relationship between labour cost per patient and the size of intensive care units: a multicentre prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Early versus Late Parenteral Nutrition in Critically Ill Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Drotrecogin alfa (activated) in adults with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Septic Shock — Evaluating Another Failed Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Evaluating the use of recombinant human activated protein C in adult severe sepsis: results of the Surviving Sepsis Campaign

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Activated protein C and septic shock: a propensity-matched cohort study*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Hydroxyethyl starch or saline for fluid resuscitation in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Interleukin 5 is protective during sepsis in an eosinophil-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201303-0567UP

10.1164/RCCM.201303-0567UP

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23767902